GLP-1 rapid rollout

GLP-1 rapid rollout

GLP-1 rapid rollout

Hims & Hers, 2024

Hims & Hers, 2024

Hims & Hers, 2024

Launched a new treatment for customers. Providing access to compounded GLP-1s means eligible customers can use medications with the same active ingredient as Ozempic® and Wegovy® without navigating the shortages and costs that are currently limiting access to the branded medications. Hims and Hers saw a 30% increase in stock price.

Launched a new treatment for customers. Providing access to compounded GLP-1s means eligible customers can use medications with the same active ingredient as Ozempic® and Wegovy® without navigating the shortages and costs that are currently limiting access to the branded medications. Hims and Hers saw a 30% increase in stock price.

Launched a new treatment for customers. Providing access to compounded GLP-1s means eligible customers can use medications with the same active ingredient as Ozempic® and Wegovy® without navigating the shortages and costs that are currently limiting access to the branded medications. Hims and Hers saw a 30% increase in stock price.

Company

Hims & Hers

Deliverables

Discovery, user research, requirements, testing

Date

June 2024

Context — My role & how it started I supported the team through discovery to launch within an aggresive 3 week timeline. I worked through prioritizing core design features with considerations to trade-offs and showing future visions and phasing out fast follows, allowing us to unlock medication across all states.

Extracted currency modules
Extracted currency modules
Extracted currency modules